ALLR
Price
$0.63
Change
-$0.01 (-1.56%)
Updated
May 20, 6:59 PM EST
SNPX
Price
$4.92
Change
+$0.17 (+3.58%)
Updated
May 20, 6:59 PM EST
8 days until earnings call
Ad is loading...

ALLR vs SNPX

Header iconALLR vs SNPX Comparison
Open Charts ALLR vs SNPXBanner chart's image
Allarity Therapeutics
Price$0.63
Change-$0.01 (-1.56%)
Volume$2.39M
CapitalizationN/A
Synaptogenix
Price$4.92
Change+$0.17 (+3.58%)
Volume$22.25K
CapitalizationN/A
View a ticker or compare two or three
ALLR vs SNPX Comparison Chart

Loading...

ALLRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SNPXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALLR vs. SNPX commentary
May 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLR is a Hold and SNPX is a Buy.

COMPARISON
Comparison
May 21, 2024
Stock price -- (ALLR: $0.64 vs. SNPX: $4.75)
Brand notoriety: ALLR and SNPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLR: 102% vs. SNPX: 44%
Market capitalization -- ALLR: $11.05M vs. SNPX: $5.16M
ALLR [@Biotechnology] is valued at $11.05M. SNPX’s [@Biotechnology] market capitalization is $5.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLR’s FA Score shows that 0 FA rating(s) are green whileSNPX’s FA Score has 1 green FA rating(s).

  • ALLR’s FA Score: 0 green, 5 red.
  • SNPX’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALLR and SNPX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLR’s TA Score shows that 3 TA indicator(s) are bullish while SNPX’s TA Score has 4 bullish TA indicator(s).

  • ALLR’s TA Score: 3 bullish, 3 bearish.
  • SNPX’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, SNPX is a better buy in the short-term than ALLR.

Price Growth

ALLR (@Biotechnology) experienced а -19.23% price change this week, while SNPX (@Biotechnology) price change was +3.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.93%. For the same industry, the average monthly price growth was +5.91%, and the average quarterly price growth was +63.66%.

Reported Earning Dates

ALLR is expected to report earnings on May 15, 2023.

SNPX is expected to report earnings on May 29, 2024.

Industries' Descriptions

@Biotechnology (+1.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALLR with price predictions.
OPEN
A.I.dvisor published
a Summary for SNPX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ALLR($11M) has a higher market cap than SNPX($5.16M). SNPX YTD gains are higher at: 1646.966 vs. ALLR (15.950).
ALLRSNPXALLR / SNPX
Capitalization11M5.16M213%
EBITDAN/AN/A-
Gain YTD15.9501646.9661%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total Cash166KN/A-
Total Debt1.3MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ALLRSNPX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 20 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
ALLRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SNPXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOX81.75-0.36
-0.44%
Amdocs Limited
PRVA16.90-0.10
-0.59%
Privia Health Group
KRT28.53-0.17
-0.59%
Karat Packaging
VTSI10.11-0.35
-3.35%
VirTra
AGFY0.33-0.01
-3.54%
Agrify Corp

ALLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLR has been closely correlated with SNPX. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALLR jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLR
1D Price
Change %
ALLR100%
-5.02%
SNPX - ALLR
87%
Closely correlated
-3.26%
AGEN - ALLR
87%
Closely correlated
+3.43%
RNAC - ALLR
86%
Closely correlated
+0.34%
NCNA - ALLR
86%
Closely correlated
-2.72%
NRXP - ALLR
81%
Closely correlated
+0.57%
More

SNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNPX has been closely correlated with RNAC. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNPX jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPX
1D Price
Change %
SNPX100%
-3.26%
RNAC - SNPX
92%
Closely correlated
+0.34%
NCNA - SNPX
92%
Closely correlated
-2.72%
AGEN - SNPX
91%
Closely correlated
+3.43%
ALLR - SNPX
87%
Closely correlated
-5.02%
TCON - SNPX
84%
Closely correlated
-6.54%
More